Stock Screener App

무료 -

설치하다

10.25

4.41% -0.63

아타라 (ATRA)

개요 뉴스 가격 이력 옵션 체인 Financials ATRA 왜 하락? 토론 예측

Atara Biotherapeutics Inc 주식(ATRA)의 최신 뉴스

Discipline and Rules-Based Execution in ATRA Response - Stock Traders Daily

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach Out - ACCESS Newswire

ATRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Atara Biotherapeutics, Inc.(NasdaqGS:ATRA) dropped from Russell 3000E Value Benchmark - marketscreener.com

Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Connect - ACCESS Newswire

Atara Biotherapeutics Inc Actuals & Estimates (GETTEX:AT20) - TradingView

Atara Biotherapeutics Inc Actuals & Estimates (SWB:AT20) - TradingView

ATRA News | ATARA BIOTHERAPEUTICS INC (NASDAQ:ATRA) - ChartMill

Atara Biotherapeutics (NASDAQ: ATRA) appoints CRCFO consultant as interim CFO - Stock Titan

Atara Biotherapeutics Inc Actuals & Estimates (NASDAQ:ATRA) - TradingView

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

ATRA Forecast — Price Target — Prediction for 2027 - TradingView

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Atara Biotherapeutics Inc (ATRA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Atara Biotherapeutics Inc (ATRA) Institutional Confidence - TradingKey

Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Behavioral Patterns of ATRA and Institutional Flows - Stock Traders Daily

Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Shareholders to Connect - ACCESS Newswire

Atara Biotherapeutics Inc (ATRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Atara Biotherapeutics Inc (ATRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Atara Biotherapeutics Inc (ATRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Atara Biotherapeutics Inc (ATRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Atara Biotherapeutics Inc (ATRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Atara Biotherapeutics Inc (ATRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Atara Biotherapeutics Inc (ATRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect - ACCESS Newswire

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cherry Brian N - Moomoo

Atara Biotherapeutics (ATRA) director awarded 24,000 restricted stock units - Stock Titan

Atara Biotherapeutics (NASDAQ: ATRA) director reports 38,320-share common stock holding - Stock Titan

Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Atara Biotherapeutics Adds Independent Director to Board - The Globe and Mail

Atara Biotherapeutics appoints Brian Cherry to board By Investing.com - Investing.com Australia

Atara Biotherapeutics appoints Brian Cherry to board - Investing.com

New Atara (NASDAQ: ATRA) director and 2026 shareholder vote outcomes - Stock Titan

Atara Biotherapeutics Announces Changes to Its Board of Directors - The Joplin Globe

symbol__ Stock Quote Price and Forecast - CNN

Atara Biotherapeutics (ATRA) director granted 12,000 restricted stock units - Stock Titan

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K - Moomoo

Atara Biotherapeutics (ATRA) director receives 12,000-share RSU grant - Stock Titan

Atara Biotherapeutics (ATRA) awards director 12,000 RSUs and reports fund holdings - Stock Titan

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

ATRA: All proposals, including director elections and equity plan amendment, were approved - TradingView

Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Atara Biotherapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus

2026-06-09 | Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ATRA | Press Release - Stockhouse

(ATRA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

2026-06-07 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect | NDAQ:ATRA | Press Release - Stockhouse

ATRA stock shoots up 82% in a month: Here's what you should know - MSN

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

2026-06-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Stockholders to Learn More About the Investigation | NDAQ:ATRA | Press Release - Stockhouse

Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Price Today & Analysis - Gotrade

Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Investors to Inquire about Securities Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeuti - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Reach Out - ACCESS Newswire

2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Reach Out | NDAQ:ATRA | Press Release - Stockhouse

Atara Biotherapeutics (ATRA) Drops Over 6% as Stock Nears Critical Support LevelVolatility Smirk - Město Břeclav

How (ATRA) Movements Inform Risk Allocation Models - Stock Traders Daily

2026-05-28 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach Out | NDAQ:ATRA | Press Release - Stockhouse

INSM

$113.18

1.95%

ROIV

$35.27

0.23%

RPRX

$58.09

0.07%

ONC

$305.00

0.85%

MRNA

$82.23

0.32%

RVMD

$190.47

0.31%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개